Status:
RECRUITING
Telehealth Intervention for Autism Spectrum Disorder
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Montefiore Medical Center
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
4-12 years
Phase:
NA
Brief Summary
Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges parti...
Detailed Description
Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children1. As a lifelong condition, individuals with ASD exp...
Eligibility Criteria
Inclusion
- Diagnosis of Autism Spectrum Disorder
- Between the ages of 4 years 0 months and 12 years 0 months
- Evidence of sensory symptoms based on the Sensory Processing Measure
- Family is willing to participate
- Physically able to participate in active, sensorimotor activities
Exclusion
- Primary (visual or auditory) uncorrected sensory deficits
- Do not meet age or diagnostic criteria
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04832152
Start Date
March 1 2023
End Date
June 30 2024
Last Update
April 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rose R. Kennedy Children's Evaluation and Rehabilitation Center (CERC) at Montefiore
The Bronx, New York, United States, 10461